GLIVEC
IMATINIB
Public price
11.940,00 MAD
Reimbursement base
3.800,00 MAD
Active substance
IMATINIB
Reimbursable
What is this medicine?
Imatinib mesylate is a kinase inhibitor indicated for the treatment of various types of leukemia, myeloproliferative diseases, and specific stromal tumors.
Verified summary
IMATINIB, COMPRIME PELLICULE, 100 MG, 1 BOITE 60 COMPRIME PELLICULE
Common uses
Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML),Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL),Myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements,Aggressive systemic mastocytosis (ASM),Hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL),Unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (DFSP),Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST),Adjuvant treatment following resection of Kit (CD117) positive GIST
Class
kinase inhibitor
Availability note
Reimbursable
Hospital price
11.714,00 MAD
Strength
100 MG
Form
COMPRIME PELLICULE
Presentation
1 BOITE 60 COMPRIME PELLICULE
Type
P
Therapeutic class
ANTINEOPLASIQUE CYTOTOXIQUE
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2017-12-18: 11.940,00 MAD
Available presentations and strengths
Medicines with the same active substance
CEMIVIL 100 MG
100 MG · Boite de 30
848,00 MAD
IMATINIB ZENITH 100 MG
100 MG · Boite de 30
963,00 MAD
CEMIVIL 400 MG
400 MG · Boite de 30
2.010,00 MAD
IMATINIB ZENITH 400 MG
400 MG · Boite de 30
3.016,00 MAD
IMATINIB COOPER 100 MG
100 MG · Boîte de 120
3.500,00 MAD
IMATEC 100 MG
100 MG · Boîte de 120
3.503,00 MAD
IMATEC
100 MG · 1 BOITE 120 GELULE
3.800,00 MAD
IMATINIB COOPER
100 MG · 1 BOITE 120 GELULE
3.800,00 MAD